Patents by Inventor Peter Lander

Peter Lander has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds and methods for treating dyslipidemia
    Publication number: 20070173526
    Abstract: The present invention discloses compounds of formula (I) wherein A, n, q, K, W, X, Y; Z, R1, R2, R3, R4, R5, and R6 are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating dyslipidemia and its sequelae.
    Type: Application
    Filed: March 17, 2005
    Publication date: July 26, 2007
    Applicant: ELI LILLY AND COMPANY
    Inventors: Michael Bell, Guoqing Cao, Ana Escribano, Maria Fernandez, Peter Lander, Nathan Mantlo, Eva Martin de la Nava, Ana Mateo Herranz, Daniel Mayhugh, Xiaodong Wang
  • Indole-derivative modulators of steroid hormone nuclear receptors
    Publication number: 20060235222
    Abstract: The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising an effective amount of a compound of Formula I in combination with a suitable carrier, diluent, or excipient, and methods for treating physiological disorders, particularly congestive heart disease, comprising administering to a patient in thereof an effective amount of a compound of Formula I.
    Type: Application
    Filed: January 20, 2004
    Publication date: October 19, 2006
    Applicant: ELI LILLY AND COMPANY
    Inventors: Michael Bell, Konstantinos Gavardinas, Douglas Gernert, Timothy Grese, Prabhakar Jadhav, Peter Lander, Mitchell Steinberg
  • Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators
    Publication number: 20050054712
    Abstract: he present invention relates to methods of treating pathological disorders susceptible to steroid hormone nuclear receptor modulation, particularly congestive heart failure, comprising administering to a patient in need thereof an effective amount of a compound of the formula: I or a pharmaceutically acceptable salt thereof. In addition, the present invention provides novel pharmaceutical compounds of Formula I, including the pharmaceutically acceptable salts thereof, as well as pharmaceutical compositions which comprise as an active ingredient a compound of Formula I.
    Type: Application
    Filed: March 11, 2003
    Publication date: March 10, 2005
    Inventors: Timothy Grese, Prabhakar Jadhav, David Neel, Mitchell Steinberg, Peter Lander